Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Topical Amitriptyline, Ketamine and Lidocaine in Neuropathic Pain Caused by Radiation Skin Reaction: a Pilot Study

To see complete record on, please visit this link

Id: NCT00798083

Organisation Name: British Columbia Cancer Agency

Overal Status: Completed

Start Date: April 2008

Last Update: June 22, 2011

Lead Sponsor: British Columbia Cancer Agency

Brief Summary: To investigate if topical amitriptyline 2%, ketamine 1%, and lidocaine 5% in pluronic lecitine organogel (AKL in PLO gel) can improve management of neuropathic pain from radiation skin reactions adjunctively or better than standard treatment.

  • Neuropathic Pain Secondary to Radiation Therapy

Total execution time in seconds: 0.29207491874695